Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: A prospective study of safety and immunogenicity

Pediatric Infectious Disease Journal

Volumn 28, Issue 8, 2009, Pages 688-692

  Barton, Michelle ^a   Wasfy, Samia ^a   Dipchand, Anne I ^a   Hébert, Diane ^a   Ng, Vicky ^a   Solomon, Melinda ^a   Fecteau, Anne ^a   Stephen, Derek ^b   Allen, Upton ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Immunogenicity; Pneumococcal conjugate vaccine; Safety; Transplant recipients

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; RISK FACTOR; SEROLOGY; SEROTYPING; SKIN REDNESS; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 68649099502     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31819d97be     Document Type: Article

References (20)

1. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006: 527-537.
2. National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine. Can Commun Dis Rep. 2002;28:1-32.
3. Stovall SH, Ainley KA, Mason EO, et al. Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J. 2001;20:946-950.
4. Schutze GE, Mason EO, Wald ER, et al. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001;33:16-21.
5. Tran L, Hébert D, Dipchand A, et al. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant. 2005;9:183-186.
6. Scheifele D, Halperin S, Pelletier L, et al. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis. 2000;31:58-64.
7. Bjornson G, Scheifele D, Binder F, et al. Population-based incidence rate of invasive pneumococcal infection in children: Vancouver, 1994-1998. CCDR. 2000;26:149-151.
8. 197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis. 1999;18:757-763.
9. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatric Infect Dis J. 2000;19:187-195.
10. Beigel J, Kohl KS, Khuri-Bulos N, et al. Rash including Mucosal involvement: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine. 2007;25:5697-5706.
11. Wernette CM, Frash CE, Madore D, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Immunol. 2003;10:514-519.
12. Jodar L, Butler J, Carlone G, et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine. 2003;21:3265-3272.
13. Schroter GP, West JC, Weil R III. Acute bacteremia in asplenic renal transplant patients. JAMA. 1997;237:2207-2208.
14. Linnemann CC Jr, First MR. Risk of pneumococcal infections in renal transplant patients. JAMA. 1979;241:2619-2621.
15. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. MMWR Recomm Rep. 2000; 49(RR-9):1-38.
16. Lin PL, Michaels MG, Green M, et al. Safety and immunogenicity of the American Academy of Pediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics. 2005;116:160-167.
17. Amber IJ, Gilbert E, Schiffman, et al. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation. 1990;49: 122-125.
18. McDonald N, Halperin SA, Law BJ, et al. Induction of immunologic memory by conjugated vs plain meningococcal c polysaccharide vaccine in toddlers. JAMA. 1998;280:1685-1689.
19. Valevainen M, Eklund C, Eskola J, et al. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines in infants. JID. 2001;184:789-793.
20. Temime L, Guillemot D, Boelle PY. Short and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother. 2004;48:2206-2213.